Plasma Omega-3 Fatty Acids and Risk for Incident Dementia in the UK Biobank Study : A Closer Look
Dietary omega-3 fatty acids are promising nutrients in dementia. Several prospective cohort studies have examined the relationships between circulating omega-3 (an objective biomarker of dietary intake) and incident dementia, the largest to date being a report from the UK Biobank (n = 102,722). Given the recent release of new metabolomics data from baseline samples from the UK Biobank, we re-examined the association in a much larger sample (n = 267,312) and also focused on associations with total omega-3, docosahexaenoic acid (DHA), and non-DHA omega-3. Using Cox regression models, we observed that the total omega-3 status was inversely related to the risk of Alzheimer's (Q5 vs. Q1, hazard ratio [95% confidence interval] = 0.87 [0.76; 1.00]) and all-cause dementia (Q5 vs. Q1, 0.79 [0.72; 0.87]). The strongest associations were observed for total omega-3 (and non-DHA omega-3) and all-cause dementia. In prespecified strata, we found stronger associations in men, and in those aged ≥60 years at baseline (vs. those aged 50-59). Thus, in the largest study to date on this topic, we confirmed the favorable relationships between DHA and risk for dementia, and we also found evidence that non-DHA omega-3 may be beneficial. Finally, we have better defined the populations most likely to benefit from omega-3-based interventions.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
Nutrients - 15(2023), 23 vom: 23. Nov. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sala-Vila, Aleix [VerfasserIn] |
---|
Links: |
---|
Themen: |
Alzheimer’s disease |
---|
Anmerkungen: |
Date Revised 09.12.2023 published: Electronic Citation Status In-Process |
---|
doi: |
10.3390/nu15234896 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM365595705 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM365595705 | ||
003 | DE-627 | ||
005 | 20231229123144.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/nu15234896 |2 doi | |
028 | 5 | 2 | |a pubmed24n1227.xml |
035 | |a (DE-627)NLM365595705 | ||
035 | |a (NLM)38068754 | ||
035 | |a (PII)4896 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sala-Vila, Aleix |e verfasserin |4 aut | |
245 | 1 | 0 | |a Plasma Omega-3 Fatty Acids and Risk for Incident Dementia in the UK Biobank Study |b A Closer Look |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 09.12.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status In-Process | ||
520 | |a Dietary omega-3 fatty acids are promising nutrients in dementia. Several prospective cohort studies have examined the relationships between circulating omega-3 (an objective biomarker of dietary intake) and incident dementia, the largest to date being a report from the UK Biobank (n = 102,722). Given the recent release of new metabolomics data from baseline samples from the UK Biobank, we re-examined the association in a much larger sample (n = 267,312) and also focused on associations with total omega-3, docosahexaenoic acid (DHA), and non-DHA omega-3. Using Cox regression models, we observed that the total omega-3 status was inversely related to the risk of Alzheimer's (Q5 vs. Q1, hazard ratio [95% confidence interval] = 0.87 [0.76; 1.00]) and all-cause dementia (Q5 vs. Q1, 0.79 [0.72; 0.87]). The strongest associations were observed for total omega-3 (and non-DHA omega-3) and all-cause dementia. In prespecified strata, we found stronger associations in men, and in those aged ≥60 years at baseline (vs. those aged 50-59). Thus, in the largest study to date on this topic, we confirmed the favorable relationships between DHA and risk for dementia, and we also found evidence that non-DHA omega-3 may be beneficial. Finally, we have better defined the populations most likely to benefit from omega-3-based interventions | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Alzheimer’s disease | |
650 | 4 | |a DHA | |
650 | 4 | |a biomarkers | |
650 | 4 | |a dementia | |
650 | 4 | |a diet | |
650 | 4 | |a docosahexaenoic acid | |
650 | 4 | |a fatty acids | |
650 | 4 | |a lipidomics | |
700 | 1 | |a Tintle, Nathan |e verfasserin |4 aut | |
700 | 1 | |a Westra, Jason |e verfasserin |4 aut | |
700 | 1 | |a Harris, William S |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nutrients |d 2009 |g 15(2023), 23 vom: 23. Nov. |w (DE-627)NLM206140738 |x 2072-6643 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2023 |g number:23 |g day:23 |g month:11 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/nu15234896 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 15 |j 2023 |e 23 |b 23 |c 11 |